Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q2 2024
Institutional positions in Calidi Biotherapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +1 vs. Q1 2024
- Shares held
- 2.68M
- −80.2K (−2.9%) vs. Q1 2024
- Total value
- $523.2K
- −$1.03M (−66.4%) vs. Q1 2024
- New holders
- 10
- 4 more added
- Sold out
- 9
- 8 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Red Wave Investments LLC | 624,602 | $124.9K | 0.05% | −20,000−3.1% | Reduced |
| CPR Investments Inc. | 560,000 | $112.0K | 0.09% | +490,000+700.0% | Added |
| RS Crum Inc. | 263,470 | $52.7K | 0.01% | +252,616+2,327.4% | Added |
| Delta Investment Management, LLC | 210,230 | $42.0K | 0.01% | +200,000+1,955.0% | Added |
| Citadel Advisors LLC | 125,905 | $25.2K | 0.00% | +125,905 | New |
| Finepoint Capital LP | 125,000 | $25.0K | 0.01% | 00.0% | Unchanged |
| HRT Financial LP | 101,390 | $20.0K | 0.00% | +87,319+620.6% | Added |
| Driehaus Capital Management LLC | 94,697 | $18.9K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 125,000 | $12.8K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 62,500 | $12.5K | 0.00% | +62,500 | New |
| Marshall Wace, LLP | 61,869 | $12.4K | 0.00% | 00.0% | Unchanged |
| Governors Lane LP | 47,349 | $9.47K | 0.00% | −47,348−50.0% | Reduced |
| XTX Topco Ltd | 42,964 | $8.59K | 0.00% | +42,964 | New |
| 683 Capital Management, LLC | 37,879 | $7.58K | 0.00% | −10,137−21.1% | Reduced |
| Magnetar Financial LLC | 33,638 | $6.31K | 0.00% | −29,494−46.7% | Reduced |
| Virtu Financial LLC | 25,965 | $5.00K | 0.00% | −16,097−38.3% | Reduced |
| DLK Investment Management, LLC | 20,812 | $4.16K | 0.00% | +20,812 | New |
| Morgan Stanley | 19,187 | $3.84K | 0.00% | −38,374−66.7% | Reduced |
| Vanguard Group Inc | 14,939 | $2.99K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 12,900 | $2.58K | 0.00% | +12,900 | New |
| Cable Car Capital LLC | 11,277 | $2.25K | 0.00% | −461,483−97.6% | Reduced |
| Two Sigma Securities, LLC | 11,132 | $2.23K | 0.00% | +11,132 | New |
| Creative Planning | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Financial Counselors Inc | 10,000 | $2.00K | 0.00% | +10,000 | New |
| Cetera Investment Advisers | 10,000 | $2.00K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 8,422 | $1.68K | 0.00% | −9,258−52.4% | Reduced |
| CVA Family Office, LLC | 5,000 | $1.00K | 0.00% | +5,000 | New |
| BlackRock Inc. | 2,588 | $518 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,525 | $505 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 273 | $55 | 0.00% | +273 | New |
| The PNC Financial Services Group, Inc. | 100 | $20 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10 | $2 | 0.00% | 00.0% | Unchanged |
| Meteora Capital, LLC | 0 | $0 | 0.00% | −249,810−100.0% | Sold out |
| Spectrum Asset Management, Inc. (NB/CA) | 0 | $0 | 0.00% | −166,494−100.0% | Sold out |
| Apollo Management Holdings, L.P. | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −107,110−100.0% | Sold out |
| Evermay Wealth Management LLC | 0 | $0 | 0.00% | −63,416−100.0% | Sold out |
| Pegasus Partners Ltd. | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Pure Financial Advisors, Inc. | 0 | $0 | 0.00% | −11,892−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −599−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −139−100.0% | Sold out |